A Strategic Collaboration Improving Healthcare M&A Processes

BETTER TOGETHER

There’s a Prevalent Problem Across Healthcare M&A Transactions; Incomplete and Poorly Organized Data Stalls Deals for All Stakeholders.

The strategic collaboration between Aesto Health and Veradigm is improving M&A processes before, during, and after acquisitions for healthcare buyers, sellers, and bankers by removing barriers to healthcare-related deal data and organizing it for clear decision-making.

Aesto Health simplifies healthcare data exchange before, during, and after care center acquisitions. Aesto Health leverages its SaaS platform to extract data from healthcare systems and reformat it for various M&A use cases such as due diligence data needs, healthcare system conversions, and benchmarking asset performance against investment thesis KPIs post-acquisition.

Aesto Health’s Acquisition Analytics extracts critical due diligence data points directly from a target system and reformat the data inside to provide a more consistent and comprehensive due diligence data for simplified analysis and speed to LOI.

Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions, all working together to transform healthcare insightfully.

Veradigm’s Acquisition Insights evaluates forty key efficiency and effectiveness metrics so decision-makers can identify opportunities to drive better outcomes, improved revenue, increased productivity, and streamlined operations for greater efficiencies across their portfolio.

BETTER TOGETHER

By combining Aesto Health and Veradigm’s acquisition tools, the deliverables offer unparalleled access to information not typically provided during operational or financial due diligence.

This comprehensive solution gets you to LOI quicker, with more confidence and a fraction of the manual data exchange required by buyers and sellers in a traditional due diligence workflow.

MORE DATA + BETTER ANALYTICS = LESS RISK

Time and Cost Reduction

AUTOMATION AND EXPERIENCE REDUCE TIME OF THE DUE DILIGENCE PROCESS BY 30%

Allows PE resources to focus on decision-making, not data-gathering

Data Accuracy and Normalization

PROVEN PROCESS TO OBTAIN DATA AND NORMALIZE THE FIRST TIME

Removes the painful back and forth between practice, vendor and PE resources

Breadth of Data Previously Unavailable

LEVERAGES DATA AND EXPERTISE ACROSS THOUSANDS OF PROVIDERS

Detailed clinical, financial and operational data with benchmarking enables informed decisions

Leverage Data to Drive Ongoing Results

ANALYTICS UTILIZED FOR RECOMMENDATIONS ON PROCESS AND TECHNOLOGY IMPROVEMENTS

Analytics delivers financial and clinical upside opportunities prior to any technology changes

Healthcare Groups Are Leveraging This New Technology for Operations and Business Development.

Increase Speed, Simplicity, and Accuracy in Your Transactions.

Aesto Analytics makes the most accurate data readily available and accelerates the acquisition process with an easy-to-use platform.

Empower Your Team with Purpose-Built Healthcare M&A Technology

  • Quickly obtain and organize accurate deal data from prospective sellers, and beat your competitors to the letter of intent.
  • Avoid wasting valuable time on prospects that aren’t a good fit.
  • Identify opportunities for post-acquisition margin improvements.
  • Analyze, implement and measure margin improvements across acquired assets in your portfolio.

Transforming health, Insightfully.

Drive Better Decision-Making with Actionable Data

  • Time and Cost Reduction Focus on decision-making rather than data-gathering
  • Data Accuracy and Normalization – Eliminates the painful time delays between the buyer, seller, and banker
  • Breadth of Data Previously Unavailable – Detailed clinical, financial, and operational data with benchmarking enables informed decisions
  • Leverage Data to Drive Ongoing Results – Financial and clinical upside opportunities drive process and technology improvements

Due Diligence Output Delivers Unmatched Insights

Examples include:

  • Accuracy and matching of financials
  • Quality of earnings around coding frequency and E&M utilization
  • Patient wait time and walkaway rates
  • No-show and schedule churn
  • Provider utilization and capacity
  • Days outstanding in AR and Clean Claim Rates

Technology Capabilities for Post-Acquisition Growth

  • Trough Elimination: Reduce the revenue trough through Transition Services, Veradigm Revenue Cycle Services, and Guided Scheduling
  • Margin Improvement: Solutions that focus on financial improvement and patient care with limited provider disruption such as Veradigm Practice Management, Integrated Clearinghouse, Consumer Engagement, and Proactive Care
  • Performance Measurement: Ongoing consolidated data and reporting through VPM, Practice Analytics, Curve Analytics, and Aesto’s Acquisition Analytics, while leveraging a consolidated financial and billing platform

“Using this solution, we move over a month faster getting to the Letter of Intent.”

– Colleen Ryan, Regional Dir. Business Dev

AESTO | Acquisition Analytics

Improve Your Processes Before, During, and After Practice Acquisitions

7

Be first to the Letter of Intent.

Business development teams use Aesto tools to obtain seller data fast and create more accurate pro formas models.

MAKE WELL-INFORMED DECISIONS.

Executives use Aesto tools and dashboards to compare deals and measure practice performance.

Simplify the Exchange of Data.

Integration teams use Aesto tools to organize and migrate acquired data.

Keep providers happy.

Providers use Aesto tools to easily access legacy patient records post-acquisition.

Automate diligence steps to simplify your transactions.